European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 131, Issue 1 , Pages 21-27 , March 2007

Population-based case–control study of allergic rhinitis during pregnancy for birth outcomes

  • Ákos Somoskövi

      Affiliations

    • Department of Respiratory Medicine, School of Medicine, Semmelweis University, 1536 Budapest 114, P.O. Box 250, Budapest, Hungary
    • Corresponding Author InformationCorresponding author. Tel.: +36 309 633 398; fax: +36 1 214 2498.
    • ,
  • Zoltán Bártfai

      Affiliations

    • Department of Respiratory Medicine, School of Medicine, Semmelweis University, 1536 Budapest 114, P.O. Box 250, Budapest, Hungary
    • ,
  • Lilla Tamási

      Affiliations

    • Department of Respiratory Medicine, School of Medicine, Semmelweis University, 1536 Budapest 114, P.O. Box 250, Budapest, Hungary
    • ,
  • Judit Kocsis

      Affiliations

    • III Department of Internal Medicine, School of Medicine, Semmelweis University, Budapest, Hungary
    • ,
  • Erzsébet Puhó

      Affiliations

    • National Institute for Epidemiology, Department of Human Genetics and Teratology, Budapest, Hungary
    • Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary
    • ,
  • Andrew E. Czeizel

      Affiliations

    • Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary

Received 17 January 2005 ,Revised 24 October 2005 ,Accepted 27 November 2005.

References 

  1. Incaudo GA. Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation. Clin Rev Allergy Immunol. 2004;27(2):159–177
  2. Sibbald B. Epidemiology of allergic rhinitis. In:  Burr ML editors. Epidemiology of clinical allergy. Monographs in allergy. Basel: Karger; 1993;p. 61–79
  3. Mazzotta P, Loebstein R, Koren G. Treating allergic rhinitis in pregnancy. Safety considerations. Drug Safety. 1999;20:361–375
  4. Ellegard E, Hellgren M, Karlsson G. The incidence of pregnancy rhinitis. Gynecol Obstet Invest. 2000;49:98–101
  5. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol. 1997;99:S742–S749
  6. Moretti ME, Caprara D, Coutinho CJ, et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol. 2003;111:479–483
  7. Czeizel AE, Rockenbauer M, Siffel C, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology. 2001;63:176–185
  8. Czeizel AE. First 25 years of the Hungarian Congenital Abnormality Registry. Teratology. 1997;55:299–305
  9. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety. 2003;12:409–416
  10. Savilahti E, Siltanen M, Pekkamen J, Kajosaari M. Mothers of very low birth weight infants have less atopy than mothers of full-term infants. Clin Exp Allergy. 2004;34:1851–1854
  11. Shepard TH. Catalog of teratogenic agents. 9th ed.. Baltimore: Johns Hopkins University Press; 1998;
  12. Czeizel AE, Elődi E, Tóth J. An epidemiological study on undescended testis. J Urol. 1981;126:524–527
  13. Beeley L. Adverse effects of drugs in later pregnancy. Clin Obstet Gynecol. 1981;8:275–290

PII: S0301-2115(05)00676-7

doi: 10.1016/j.ejogrb.2005.11.035

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 131, Issue 1 , Pages 21-27 , March 2007

Article Tools